2011 Q4 Form 10-Q Financial Statement

#000104396111000007 Filed on November 10, 2011

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3 2010 Q3
Revenue $8.571M $8.253M $4.419M
YoY Change 68.39% 86.76% -12.5%
Cost Of Revenue $3.290M $3.808M $2.402M
YoY Change 20.96% 58.53% 4.89%
Gross Profit $5.283M $4.445M $2.017M
YoY Change 121.97% 120.38% -26.65%
Gross Profit Margin 61.64% 53.86% 45.64%
Selling, General & Admin $4.880M $4.364M $2.159M
YoY Change 47.43% 102.13% -2.75%
% of Gross Profit 92.37% 98.18% 107.04%
Research & Development $570.0K $515.0K $613.0K
YoY Change 62.86% -15.99% -34.79%
% of Gross Profit 10.79% 11.59% 30.39%
Depreciation & Amortization $590.0K $481.0K $140.0K
YoY Change 210.53% 243.57% -26.32%
% of Gross Profit 11.17% 10.82% 6.94%
Operating Expenses $5.440M $4.884M $2.844M
YoY Change 48.63% 71.73% -10.0%
Operating Profit -$157.0K -$439.0K -$827.0K
YoY Change -87.73% -46.92% 101.71%
Interest Expense -$240.0K -$240.0K $0.00
YoY Change 2300.0%
% of Operating Profit
Other Income/Expense, Net $830.0K -$2.000K $0.00
YoY Change 31.75%
Pretax Income $430.0K -$1.279M -$827.0K
YoY Change -158.9% 54.66% 106.75%
Income Tax $170.0K -$9.000K $71.00K
% Of Pretax Income 39.53%
Net Earnings $264.0K -$1.270M -$898.0K
YoY Change -134.29% 41.43% 142.7%
Net Earnings / Revenue 3.08% -15.39% -20.32%
Basic Earnings Per Share
Diluted Earnings Per Share $26.00M -$127.0M -$90.00M
COMMON SHARES
Basic Shares Outstanding 49.38M shares 49.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2011 Q4 2011 Q3 2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.950M $1.420M $4.590M
YoY Change 43.48% -69.06% -1.5%
Cash & Equivalents $4.946M $1.423M $3.170M
Short-Term Investments
Other Short-Term Assets $820.0K $1.336M $650.0K
YoY Change 29.13% 105.54% -1.52%
Inventory $3.859M $3.306M $3.660M
Prepaid Expenses
Receivables $7.573M $7.591M $3.540M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.20M $13.66M $12.43M
YoY Change 14.39% 9.86% -8.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.856M $1.597M $1.050M
YoY Change 15.86% 52.1% -0.94%
Goodwill $6.440M $6.275M
YoY Change 2.63%
Intangibles $7.966M $8.325M
YoY Change -11.11%
Long-Term Investments
YoY Change
Other Assets $102.0K $121.0K
YoY Change -33.77%
Total Long-Term Assets $16.36M $16.32M $1.510M
YoY Change -3.7% 980.66% -14.2%
TOTAL ASSETS
Total Short-Term Assets $17.20M $13.66M $12.43M
Total Long-Term Assets $16.36M $16.32M $1.510M
Total Assets $33.56M $29.97M $13.94M
YoY Change 4.79% 115.02% -9.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.609M $1.721M $890.0K
YoY Change 91.84% 93.37% 11.25%
Accrued Expenses $2.782M $3.834M $3.390M
YoY Change -13.9% 13.1% 18.12%
Deferred Revenue
YoY Change
Short-Term Debt $3.082M $247.0K $0.00
YoY Change 211.63%
Long-Term Debt Due $3.703M $1.234M
YoY Change
Total Short-Term Liabilities $16.33M $10.10M $4.280M
YoY Change 97.84% 136.07% 16.94%
LONG-TERM LIABILITIES
Long-Term Debt $4.937M $7.405M $0.00
YoY Change -42.86%
Other Long-Term Liabilities $1.249M $974.0K $350.0K
YoY Change 48.16% 178.29% 75.0%
Total Long-Term Liabilities $6.186M $8.379M $350.0K
YoY Change -34.77% 2294.0% 75.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.33M $10.10M $4.280M
Total Long-Term Liabilities $6.186M $8.379M $350.0K
Total Liabilities $22.51M $29.68M $4.630M
YoY Change 2.01% 541.1% 19.64%
SHAREHOLDERS EQUITY
Retained Earnings -$142.8M -$144.2M
YoY Change 7.11%
Common Stock $501.0K $499.0K
YoY Change 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.05M -$1.505M $9.310M
YoY Change
Total Liabilities & Shareholders Equity $33.56M $29.97M $13.94M
YoY Change 4.79% 115.02% -9.24%

Cashflow Statement

Concept 2011 Q4 2011 Q3 2010 Q3
OPERATING ACTIVITIES
Net Income $264.0K -$1.270M -$898.0K
YoY Change -134.29% 41.43% 142.7%
Depreciation, Depletion And Amortization $590.0K $481.0K $140.0K
YoY Change 210.53% 243.57% -26.32%
Cash From Operating Activities $1.120M -$990.0K -$850.0K
YoY Change -233.33% 16.47% -1800.0%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K $70.00K -$30.00K
YoY Change -98.68% -333.33% -72.73%
Acquisitions
YoY Change
Other Investing Activities -$20.00K -$120.0K -$10.00K
YoY Change 1100.0% 0.0%
Cash From Investing Activities -$110.0K -$40.00K -$40.00K
YoY Change -98.18% 0.0% -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.530M -160.0K -60.00K
YoY Change -56.23% 166.67%
NET CHANGE
Cash From Operating Activities 1.120M -990.0K -850.0K
Cash From Investing Activities -110.0K -40.00K -40.00K
Cash From Financing Activities 2.530M -160.0K -60.00K
Net Change In Cash 3.540M -1.190M -950.0K
YoY Change -416.07% 25.26% 1257.14%
FREE CASH FLOW
Cash From Operating Activities $1.120M -$990.0K -$850.0K
Capital Expenditures -$80.00K $70.00K -$30.00K
Free Cash Flow $1.200M -$1.060M -$820.0K
YoY Change -76.97% 29.27% -612.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1721000 USD
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1360000 USD
CY2010Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7601000 USD
CY2011Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7591000 USD
CY2010Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3231000 USD
CY2011Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3834000 USD
CY2011Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12231000 USD
CY2010Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11697000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1589000 USD
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1675000 USD
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
139730000 USD
CY2011Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140486000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
734000 USD
CY2011Q3 us-gaap Assets
Assets
29974000 USD
CY2010Q4 us-gaap Assets
Assets
32027000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
15034000 USD
CY2011Q3 us-gaap Assets Current
AssetsCurrent
13656000 USD
CY2010Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
170000 USD
CY2011Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
197000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3454000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1423000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4589000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5642000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2031000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1053000 USD
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49289672 shares
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49379822 shares
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49379822 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49289672 shares
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
498000 USD
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
499000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7568000 USD
CY2010Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2402000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10248000 USD
CY2011Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3808000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
523000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1506000 USD
CY2010Q3 us-gaap Dividends Payable Amount
DividendsPayableAmount
0 USD
CY2011Q3 us-gaap Dividends Payable Amount
DividendsPayableAmount
450000 USD
CY2010Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2011Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
450000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
450000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2010Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
72000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
12000 USD
CY2011Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
8000000 USD
CY2010Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1983000 USD
CY2010Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
875000 USD
CY2011Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1058000 USD
CY2011Q3 us-gaap Goodwill
Goodwill
6275000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
6275000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
4445000 USD
us-gaap Gross Profit
GrossProfit
7388000 USD
us-gaap Gross Profit
GrossProfit
13152000 USD
CY2010Q3 us-gaap Gross Profit
GrossProfit
2017000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1279000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10165000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-827000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2258000 USD
CY2010Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
71000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-120000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-121000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
137000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1418000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-940000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-131000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-20000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-18000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
245000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-44000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
268000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
269000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-90000 USD
CY2010Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8962000 USD
CY2011Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8325000 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
495000 USD
us-gaap Inventory Write Down
InventoryWriteDown
47000 USD
CY2010Q4 us-gaap Inventory Net
InventoryNet
3344000 USD
CY2011Q3 us-gaap Inventory Net
InventoryNet
3306000 USD
us-gaap Inventory Write Down
InventoryWriteDown
78000 USD
CY2011Q3 us-gaap Liabilities
Liabilities
29683000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
22070000 USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29974000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32027000 USD
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10104000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8253000 USD
CY2010Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2011Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1234000 USD
CY2011Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7405000 USD
CY2010Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8640000 USD
CY2011Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10105000 USD
CY2010Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9820000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-801000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-403000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-166000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-899000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-884000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2367000 USD
CY2010Q3 us-gaap Net Income Loss
NetIncomeLoss
-898000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-1270000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10045000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10848000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2367000 USD
CY2010Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-898000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1545000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
388000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
286000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
4884000 USD
us-gaap Operating Expenses
OperatingExpenses
15962000 USD
CY2010Q3 us-gaap Operating Expenses
OperatingExpenses
2844000 USD
us-gaap Operating Expenses
OperatingExpenses
9647000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2810000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2259000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1650000 USD
CY2010Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
843000 USD
CY2010Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-827000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-439000 USD
CY2010Q4 us-gaap Other Assets Current
OtherAssetsCurrent
635000 USD
CY2011Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1336000 USD
CY2011Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121000 USD
CY2010Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
154000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
86000 USD
CY2010Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1628000 USD
CY2011Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1363000 USD
CY2011Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
974000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2010Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
231000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
256000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
25000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
353000 USD
CY2011Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
275000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
803000 USD
CY2010Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2011Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2011Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000 USD
CY2010Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13299000 USD
CY2011Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13828000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1602000 USD
CY2011Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1597000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1432000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
57000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
165000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
659000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2010Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
613000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
515000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1952000 USD
CY2011Q3 us-gaap Restructuring Charges
RestructuringCharges
5000 USD
CY2010Q3 us-gaap Restructuring Charges
RestructuringCharges
72000 USD
us-gaap Restructuring Charges
RestructuringCharges
40000 USD
us-gaap Restructuring Charges
RestructuringCharges
72000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133317000 USD
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144165000 USD
CY2010Q3 us-gaap Sales Revenue Net
SalesRevenueNet
4419000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
14956000 USD
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
8253000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
23400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14272000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4364000 USD
CY2010Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2159000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7623000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-29000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
734000 USD
CY2010Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
989000 USD
CY2011Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
247000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000 USD
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
-1505000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
8500000 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
CY2010Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
6866000 USD
CY2011Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
600000 USD
CY2010Q4 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
1457000 USD
CY2011Q3 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
1796000 USD
CY2011Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
3879307 shares
CY2010Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
3879307 shares
CY2010Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2586205 shares
CY2011Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2586205 shares
CY2011Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2586205 shares
CY2010Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2586205 shares
CY2011Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3200000 USD
CY2010Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2351000 USD
CY2010Q4 tbio Accumulated Amortization On Intangibles
AccumulatedAmortizationOnIntangibles
519000 USD
CY2011Q3 tbio Accumulated Amortization On Intangibles
AccumulatedAmortizationOnIntangibles
1142000 USD
tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49306861 shares
CY2011Q3 tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49327527 shares
tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49228561 shares
CY2010Q3 tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49289672 shares
CY2011Q3 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3723000 USD
CY2010Q4 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3479000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-720000 USD
CY2010Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
0 USD
CY2011Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-238000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
1000 USD
tbio Other Income Expense
OtherIncomeExpense
1000 USD
tbio Other Income Expense
OtherIncomeExpense
-7355000 USD
CY2011Q3 tbio Other Income Expense
OtherIncomeExpense
-840000 USD
CY2010Q3 tbio Other Income Expense
OtherIncomeExpense
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2011Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49379822 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC

Files In Submission

Name View Source Status
0001043961-11-000007-index-headers.html Edgar Link pending
0001043961-11-000007-index.html Edgar Link pending
0001043961-11-000007.txt Edgar Link pending
0001043961-11-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20110930.xml Edgar Link completed
tbio-20110930.xsd Edgar Link pending
tbio-20110930_cal.xml Edgar Link unprocessable
tbio-20110930_def.xml Edgar Link unprocessable
tbio-20110930_lab.xml Edgar Link unprocessable
tbio-20110930_pre.xml Edgar Link unprocessable
tbio-2011930x10q.htm Edgar Link pending
tbio-ex311_2011930xq2.htm Edgar Link pending
tbio-ex312_2011930xq2.htm Edgar Link pending
tbio-ex321_2011930xq2.htm Edgar Link pending
tbio-ex322_2011930xq2.htm Edgar Link pending